Nasal Protollin in Early Symptomatic Alzheimer's Disease

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
In this research study investigators aim to learn more about a new drug called Protollin as a possible new treatment for Alzheimer\'s Disease (AD). The primary goal is to assess the safety and tolerability.
Epistemonikos ID: d2f7009827afab588d7e5c6de633fef0ee697f9b
First added on: Sep 23, 2025